Process Development Improvements Post-Pandemic

What can the biopharma industry learn from its rapid response to the COVID-19 pandemic?

In this expert interview with BioPharm International, James Blackwell, president of The Windshire Group, LLC, explains key actions the biopharma can learn from its response to the COVID-19 pandemic that can be applied to improve process development for non-pandemic development programs.

Related Content:

Process DevelopmentDevelopmentCOVID-19 Update
Drug Solutions Podcast: Outsourcing vs. Insourcing in Biopharma: Determining the Best Strategy